Featured Research

from universities, journals, and other organizations

Researchers Discover How Immune System Rids Nervous System Of Mosquito-Borne Viruses

Date:
July 17, 2001
Source:
Johns Hopkins University Bloomberg School Of Public Health
Summary:
Researchers at the Johns Hopkins Bloomberg School of Public Health have determined that neurons in the central nervous system react differently to the body’s immune defenses to rid themselves of viruses that cause encephalitis, such as West Nile and Eastern Equine Encephalitis viruses. Encephalitis is an inflammation of the brain and can cause neurological problems including, seizures, coma, and death.

Researchers at the Johns Hopkins Bloomberg School of Public Health have determined that neurons in the central nervous system react differently to the body’s immune defenses to rid themselves of viruses that cause encephalitis, such as West Nile and Eastern Equine Encephalitis viruses. Encephalitis is an inflammation of the brain and can cause neurological problems including, seizures, coma, and death.

In a study published in the July 13, 2001 issue of Science, researchers discovered that T-cells produce a protein, interferon-g, which can clear the virus in neurons located in the spinal cord and brain stem, but not in neurons located in the cerebral cortex. Neurons are cells that conduct and generate electrical impulses to carry information throughout the central nervous system. The findings add to the understanding of lymphocytes in the immune system and interactions of the central nervous system and could lead to new approaches to the treatment of viral encephalitis.

“Our previous research indicated that antibodies successfully clear infection from the central nervous system. With this study, we wanted to see if lymphocytes could also clear viral infections from the neurons,” says Diane Griffin, MD, PhD, professor and chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. “Normally, T-cells control virus infections by destroying infected cells, but that would be counterproductive for neurons, because the body does not make new neurons,” explains Dr. Griffin.

For the study, the researchers observed mice that did not have the ability to produce antibodies and compared them to normal mice. The mice were infected with Sindbis virus, a mosquito-borne virus related to other causes of encephalitis transmitted by mosquitoes, such as West Nile and Eastern Equine encephalitis viruses.

During the experiments, Gwendolyn Binder, a graduate student in the laboratory of Dr. Griffin, observed that CD4 and CD8 T-cells both successfully cleared the virus from the neurons from the spinal cord and brain stem using interferon-g. However, the neurons in the brain cortex did not react to the interferon-g in the same manner. This indicated a site-specific response to this clearance mechanism among the neurons. In addition, the researchers observed that another protein, TNF-a, produced by the T-cells was unable to clear the virus from the central nervous system.

“This research shows that virus-infected neurons do not all respond to the lymphocyte immune system in the same way to clear infection. Therefore, different combinations of antibody and T-cell immunity may be needed for control of infection and recovery from encephalitis depending on the parts of the brain or spinal cord that are infected,” adds Dr. Griffin.

B. Schofield assisted with imaging and photography for the study. Support was provided by grants from the Markey Foundation (G.K.B.) and from the National Institute of Neurological Diseases and Stroke (D.E.G.).


Story Source:

The above story is based on materials provided by Johns Hopkins University Bloomberg School Of Public Health. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins University Bloomberg School Of Public Health. "Researchers Discover How Immune System Rids Nervous System Of Mosquito-Borne Viruses." ScienceDaily. ScienceDaily, 17 July 2001. <www.sciencedaily.com/releases/2001/07/010717081312.htm>.
Johns Hopkins University Bloomberg School Of Public Health. (2001, July 17). Researchers Discover How Immune System Rids Nervous System Of Mosquito-Borne Viruses. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2001/07/010717081312.htm
Johns Hopkins University Bloomberg School Of Public Health. "Researchers Discover How Immune System Rids Nervous System Of Mosquito-Borne Viruses." ScienceDaily. www.sciencedaily.com/releases/2001/07/010717081312.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins